Generic Methotrexate - Rheumatrex
|
Your reliable supplier of generic medications.
|
|
|
Categories list
AlcoholismAlzheimer's And Parkinson'sAnalgesicsAnti-inflammatoriesAntiallergicAntibioticsAnticonvulsantsAntidepressantsAntifungalsAntiparasiticAntiviralsArthritisAsthmaBirth ControlCancerCardiovascular DiseasesCholesterolDiabetesDiureticsErectile DysfunctionEye CareGastrointestinal TractHIVHypertensionMen's HealthMental DisordersMigraineMuscle RelaxantsNeurological DisordersObesityOsteoporosisRespiratory TractSkin CareStop SmokingSurgeryUrinary TractWomen's Health
You guys were superb and true to your word, happy to be a reference for you any time and thank you - David
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Bristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the ... - MarketWatch (press release)
Asian Scientist MagazineBristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the .
- Infection Risk High in Juvenile Arthritis - MedPage Today
MedPage TodayInfection Risk High in Juvenile ArthritisMedPage TodayNote that among children with JIA, the rate of infection was not increased with methotrexate or tumor necrosis factor inhibitor use.
- New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ... - MarketWatch (press release)
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in .
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
Our billing is certified by:
Social Bookmarks Failed